Výsledky vyhledávání - Laura Rocci

  • Zobrazuji výsledky 1 - 4 z 4
Upřesnit hledání
  1. 1
    Repeated Intermittent Low-Dose Therapy with Zoledronic Acid Induces an Early, Sustained, and Long-Lasting Decrease of Peripheral Vascular Endothelial Growth Factor Levels in Cancer Patients

    Repeated Intermittent Low-Dose Therapy with Zoledronic Acid Induces an Early, Sustained, and Long-Lasting Decrease of Peripheral Vascular Endothelial Growth Factor Levels in Cancer... Autor Daniele Santini, Bruno Vincenzi, Sara Galluzzo, Fabrizio Battistoni, Laura Rocci, Olga Venditti, Gaia Schiavon, Silvia Angeletti, Federica Uzzalli, Michele Caraglia, Giordano Dicuonzo, Giuseppe Tonini

    Vydáno 2007
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  2. 2
    In vivo effects of zoledronic acid on peripheral γδ T lymphocytes in early breast cancer patients

    In vivo effects of zoledronic acid on peripheral γδ T lymphocytes in early breast cancer patients Autor Daniele Santini, Federico Martini, Maria Elisabetta Fratto, Sara Galluzzo, Bruno Vincenzi, Chiara Agrati, Federica Turchi, Paola Piacentini, Laura Rocci, John S. Manavalan, Giuseppe Tonini, Fabrizio Poccia

    Vydáno 2008
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  3. 3
    Early Magnesium Reduction in Advanced Colorectal Cancer Patients Treated with Cetuximab Plus Irinotecan as Predictive Factor of Efficacy and Outcome

    Early Magnesium Reduction in Advanced Colorectal Cancer Patients Treated with Cetuximab Plus Irinotecan as Predictive Factor of Efficacy and Outcome Autor Bruno Vincenzi, Daniele Santini, Sara Galluzzo, Antonio Russo, Fabio Fulfaro, Marianna Silletta, Fabrizio Battistoni, Laura Rocci, Bruno Beomonte Zobel, Vincenzo Adamo, Giordano Dicuonzo, Giuseppe Tonini

    Vydáno 2008
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  4. 4
    Early magnesium modifications as a surrogate marker of efficacy of cetuximab-based anticancer treatment in KRAS wild-type advanced colorectal cancer patients

    Early magnesium modifications as a surrogate marker of efficacy of cetuximab-based anticancer treatment in KRAS wild-type advanced colorectal cancer patients Autor Bruno Vincenzi, Sara Galluzzo, Daniele Santini, Laura Rocci, Fotios Loupakis, Pierpaolo Correale, Raffaele Addeo, Alice Zoccoli, Andrea Napolitano, Francesco Graziano, Annamaria Ruzzo, Alfredo Falcone, Guido Francini, Giordano Dicuonzo, Giuseppe Tonini

    Vydáno 2010
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:

Vyhledávací nástroje: